Literature DB >> 47918

Palliative urinary diversion for pelvic malignancy.

E N Brin, M Schiff, R M Weiss.   

Abstract

Palliative urinary diversion was done in 47 cases for ureteral obstruction secondary to advanced pelvic malignancy. The average survival time was 5.3 months, with only 50 per cent of the patients alive at 3 months and only 22.7 per cent alive at 6 months. After the diversion 63.8 per cent of the survival time was spent in the hospital. Patients with carcinoma of the prostate fared better than those with other sites of tumor origin, which may reflect the natural history of this tumor.

Entities:  

Mesh:

Year:  1975        PMID: 47918     DOI: 10.1016/s0022-5347(17)59536-1

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  7 in total

1.  Recurrent cancer and metastases.

Authors:  R C Hickey; M M Romsdahl; D E Johnson; S Wallace; G M Mavligit; M E Leavens; B Borgelt
Journal:  World J Surg       Date:  1982-09       Impact factor: 3.352

2.  Retroperitoneal fibrosis due to malignancy: a case report.

Authors:  M L Erton; Y N Ilker; N Ceyhan; A Akdaş
Journal:  Int Urol Nephrol       Date:  1995       Impact factor: 2.370

3.  Metastatic disease of the ureter: patterns of tumoral spread and radiologic findings.

Authors:  B Marincek; J R Scheidegger; U E Studer; R Kraft
Journal:  Abdom Imaging       Date:  1993

4.  Ureteral decompression in advanced nonurologic malignancies.

Authors:  S M Donat; P Russo
Journal:  Ann Surg Oncol       Date:  1996-07       Impact factor: 5.344

Review 5.  Malignant ureteric obstruction decompression: how much gain for how much pain? A narrative review.

Authors:  Joanna Prentice; Tarik Amer; Ali Tasleem; Omar Aboumarzouk
Journal:  J R Soc Med       Date:  2018-04       Impact factor: 5.344

6.  Acute renal failure secondary to bilateral ureteric obstruction: review of 50 cases.

Authors:  R W Norman; F G Mack; S A Awad; P Belitsky; R D Schwarz; S G Lannon
Journal:  Can Med Assoc J       Date:  1982-10-01       Impact factor: 8.262

7.  Management of urinary complications of recurrent pelvic malignancy in gynaecological practice.

Authors:  W F Hendry
Journal:  J R Soc Med       Date:  1978-07       Impact factor: 18.000

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.